TLX 4.57% $21.96 telix pharmaceuticals limited

A short notice concerning prior comments that Telix may be...

  1. 19 Posts.
    lightbulb Created with Sketch. 35
    A short notice concerning prior comments that Telix may be overvalued according to a PE metric. Even though its valuation appreciated nicely and it cannot be called a microcap anymore, I feel it would be wrong using a PE view on market cap. Due to its growth prospects and beautiful reinvestment strategy of returns, a revenue-based valuation seems appropriate. I think the UBS assessment is spot-on and still conservative. At current prices the stock continues to be essentially undervalued. Kind regards.
 
watchlist Created with Sketch. Add TLX (ASX) to my watchlist
arrow-down-2 Created with Sketch. arrow-down-2 Created with Sketch.